The Columbus Dispatch | Jack Torry
Executives of the leading pharmaceutical benefit manager companies blamed drug-makers for the high prices of prescription drugs.
The head of OptumRX accused drug companies of “anti-competitive tactics” to delay introduction of less expensive generic drugs.
Testifying Tuesday before the Senate Finance Committee, the executives sharply objected to claims that rebates paid by the manufacturers to the pharmacy benefit managers do not get passed on to consumers facing rising drug prices…
Ohio Attorney General David Yost last month sued OptumRx to recover $16 million in overcharges to the state for prescription drugs. Yost demanded repayment after first seeking mediation in the dispute on behalf of the Bureau of Workers’ Compensation, which hired OptumRx to manage pharmacy benefits for injured workers.